We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$386M
AUM Growth
-$48.5M
Cap. Flow
-$47.9M
Cap. Flow %
-12.39%
Top 10 Hldgs %
36.85%
Holding
229
New
102
Increased
14
Reduced
22
Closed
70

Sector Composition

Rank Sector Weight
1 Real Estate 19.09%
2 Healthcare 18.43%
3 Technology 16.93%
4 Consumer Discretionary 14.67%
5 Communication Services 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARYAW
126
DELISTED
ARYA Sciences Acquisiton Corp. Warrant
ARYAW
$375K 0.1%
249,999
RMTI icon
127
Rockwell Medical
RMTI
$28.2M
$359K 0.09%
+1,084
New +$550K
IDYA icon
128
IDEAYA Biosciences
IDYA
$3.56B
$354K 0.09%
+35,546
New +$387K
GPP
129
DELISTED
Green Plains Partners LP
GPP
$350K 0.09%
25,000
PVT.WS
130
DELISTED
Pivotal Acquisition Corp. Redeemable Warrants, exercisable for shares of Class A Common Stock at an
PVT.WS
$338K 0.09%
+250,000
New +$252K
DFBHW
131
DELISTED
DFB Healthcare Acquisitions Corp. Warrant
DFBHW
$323K 0.08%
258,333
MCRB icon
132
Seres Therapeutics
MCRB
$48.4M
$322K 0.08%
+5,000
New +$475K
HTGC icon
133
Hercules Capital
HTGC
$3.23B
$321K 0.08%
+25,000
New +$324K
DBVT
134
DBV Technologies
DBVT
$847M
$310K 0.08%
+3,768
New +$337K
ZEPP
135
Zepp Health
ZEPP
$69.7M
$310K 0.08%
7,742
+2,333
+43% +$97.3K
BWMCW
136
DELISTED
Boxwood Merger Corp. Warrant
BWMCW
$310K 0.08%
500,000
AVTR.PRA
137
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
$301K 0.08%
+5,000
New +$311K
CARM
138
DELISTED
Carisma Therapeutics
CARM
$300K 0.08%
+10,000
New +$299K
SHSP
139
DELISTED
SharpSpring, Inc.
SHSP
$296K 0.08%
+22,753
New +$381K
IDT icon
140
IDT Corp
IDT
$1.62B
$259K 0.07%
27,365
-86,407
-76% -$637K
CTLP
141
DELISTED
Cantaloupe
CTLP
$244K 0.06%
32,817
-45,000
-58% -$279K
FSLY icon
142
Fastly Inc
FSLY
$3.66B
$231K 0.06%
+11,411
New +$235K
PVTL
143
DELISTED
Pivotal Software, Inc.
PVTL
$211K 0.05%
+20,000
New +$355K
KERNW
144
DELISTED
Akerna Corp Warrant
KERNW
$208K 0.05%
+69,900
New +$197K
BNGO icon
145
Bionano Genomics
BNGO
$13.3M
$202K 0.05%
138
SPAQ.WS
146
DELISTED
Spartan Energy Acquisition Corp. Warrants, each whole warrant exercisable for one Class A common sto
SPAQ.WS
$194K 0.05%
217,702
HAPN
147
Happen Inc
HAPN
$2.24B
$164K 0.04%
+10,000
New +$158K
ATER icon
148
Aterian
ATER
$5.37M
$161K 0.04%
+1,667
New +$151K
FMCIW
149
DELISTED
Forum Merger II Corporation Warrant
FMCIW
$128K 0.03%
200,000
BNGOW
150
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$119K 0.03%
163,265

Similar funds

Monashee Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Monashee Investment Management held 229 positions worth $386M, down 11% from $435M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Monashee Investment Management withdrew a net $47.9M in Q2 2019, closing 70 positions and reducing 22 holdings. Its most notable exit was Bandwidth Inc, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 19% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Monashee Investment Management opened a new position in Avantor worth $13.4M.

  • Monashee Investment Management's largest Q2 2019 buy was Avantor: 699,800 shares worth $13.4M.
  • Monashee Investment Management added most to Verra Mobility in Q2 2019, an estimated $6.66M increase.
  • Monashee Investment Management's biggest Q2 2019 reduction was Equitable Holdings, cutting an estimated $13M.
  • Monashee Investment Management fully exited Bandwidth Inc in Q2 2019, selling an estimated $14.1M.
  • Monashee Investment Management's ten largest holdings make up 37% of its $386M portfolio in Q2 2019.
  • Monashee Investment Management opened 102 new positions and closed 70 in Q2 2019.
  • Monashee Investment Management's portfolio value fell 11% quarter-over-quarter to $386M.

Based on Monashee Investment Management's 13F filing for Q2 2019, filed 7 Aug 2019.